John Lim

VP, Clinical Operations

equally divided between biotech and working at contract research organizations (CROs). He was most recently the Senior Vice President of clinical operations and regulatory affairs at Turning Point Therapeutics, Inc., where he helped develop their first and lead compound, repotrectinib. Prior to Turning Point, John was Vice President at Senhwa Bi...


Roles at Artiva Biotherapeutics

  • VP, Clinical Operations

    Current role

By clicking "Continue" or continuing to use our site, you acknowledge that you accept our Privacy Policy and Terms of Use. We also use cookies to provide you with the best possible experience on our website.